Bioequivalence studies: Biometrical concepts of alternative designs and pooled analysis

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 3, 1999, Pages 225-232

  Zintzaras, E ^a   Bouka, P ^a  

^a National Drug Organization   (Greece)

Author keywords

Bioequivalence; Design; Pooled analysis; Regulatory authorities

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BIOMETRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT;

EID: 0033369822     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190024     Document Type: Article

References (9)

1. Chow S.C., Liu J.P. (1992) : Design and analysis of bioavailability and bioequivalence studies.
2. Schuirmann D.J. (1990) : Statistical evaluation of bioequivalence studies. In: Sharma K.N., Sharma K.K., Sen P. Eds. Generic Drugs, Bioequivalence and Pharmacokinetics, UCMS, Delhi, pp 119-125.
3. CPMP :Note for guidance on the investigation of bioavailability and bioequivalence. In: The Rules Governing Medicinal Products for Human Use in the Member States of the European Community, Volume III, Addendum No 2, Guidelines on the Quality, Safety & Efficacy of Medicinal Products for Human Use pp 149-168.
4. Metzler C.M. (1974) : Bioavailability - a problem in equivalence. Biometrics, 30, 309-317.
5. Jones B., Kenward M.G (1995) : Design and Analysis of Crossover Trials. London: Chapman and Hall.
6. Dilleti E., Hauschke D., Steinijans V.W. (1992) : Sample size determination for bioequivalence assessment by means of confidence intervals. Int. J. Clin. Pharmacol. Ther. Toxicol., 29, 51-58,
7. Jones B., Jarvis P., Lewis J.A., Ebbutt A.F. (1996) : Trials to assess equivalence: the importance of rigorous methods. BMJ, 313, 36-39.
8. Mead R. (1988) : Design of Experiments. Cambridge: Cambridge University Press.
9. Midha K.K, Blume H. (1993) : Report of Consensus Meeting: Biointernational '92, Conference on Bioavailability, Bioequivalence and Pharmacokinetic studies. Eur. J. Pharm. Sci., 1, 165-171.